Kineta, Inc.
Biotechnology company · Seattle, Washington, United States
Kineta, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2007. It has received 8 US government small-business research awards (SBIR/STTR) from health agencies, $7.7 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $17 million sold in a notice filed in 2022.
Kineta at a glance
What does Kineta do?
US government research funding
8 SBIR/STTR small-business research awards from US health agencies, $7.7 million in total (2008 to 2019). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute on Drug Abuse.
Private fundraising reported to the SEC
32 Form D notices; the most recent reported $17.4 million sold (2022).
Frequently asked questions about Kineta
Where is Kineta headquartered?
Kineta, Inc. is headquartered in Seattle, Washington, United States.
What does Kineta do?
Kineta, Inc. is a biotechnology company.
When was Kineta founded?
The earliest incorporation on record for Kineta, Inc. is in 2007, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.